Evidence map›Paper›PMID 30759143›Full record

ArticlePloS one2019

Interaction between nectin-1 and the human natural killer cell receptor CD96.

Veronica M Holmes, Carlos Maluquer de Motes, Paige T Richards, Jessenia Roldan, Arjun K Bhargava, Jordan S Orange, Claude Krummenacher

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. HIV-1 manipulates CD96 on CD4Science advances · 2025
    Article
  6. Multi-omics exploration of CAV1Discover oncology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Veronica M HolmesDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Carlos Maluquer de MotesDepartment of Microbial Sciences, University of Surrey, Guildford, Surrey, United Kingdom.
Paige T RichardsDepartment of Biological Sciences, Rowan University, Glassboro, New Jersey, United States of America.
Jessenia RoldanDepartment of Biological Sciences, Rowan University, Glassboro, New Jersey, United States of America.
Arjun K BhargavaDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Jordan S OrangeDepartment of Pediatrics, Columbia University, New York, New York, United States of America.
Claude KrummenacherDepartment of Biological Sciences, Rowan University, Glassboro, New Jersey, United States of America.ORCID 0000-0002-3492-4987
Rowan University · USUniversity of Pennsylvania · USColumbia University · USUniversity of Surrey · GB

Funding

GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCYR01AI120989 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORANGE, JORDAN SCOTT · 2016 to 2025
$7.7M
Directing Function at the Natural Killer Cell Secretory Immunological SynapseR01AI067946 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORANGE, JORDAN SCOTT · 2007 to 2019
$4.8M
Directing Function at the Natural Killer Cell Secretory Immunological SynapseR37AI067946 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jordan Scott Orange · 2024 to 2026
$1.5M
Immunoregulatory Activities of HSV gD Binding to its Entry ReceptorsR56AI097171 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI KRUMMENACHER, CLAUDE F · 2012 to 2012
$400k
Directing Function at the Natural Killer Cell Secretory Immunological SynapseR56AI067946 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI ORANGE, JORDAN SCOTT · 2011 to 2011
$335k
NIAID NIH HHS R01 AI067946NIAID NIH HHS R01 AI120989NIAID NIH HHS R37 AI067946NIAID NIH HHS R56 AI067946NIAID NIH HHS R56 AI097171
6 · The paper itself

Abstract

Regulation of Natural Killer (NK) cell activity is achieved by the integration of both activating and inhibitory signals acquired at the immunological synapse with potential target cells. NK cells express paired receptors from the immunoglobulin family which share common ligands from the nectin family of adhesion molecules. The activating receptor CD226 (DNAM-1) binds to nectin-2 and CD155, which are also recognized by the inhibitory receptor TIGIT. The third receptor in this family is CD96, which is less well characterized and may have different functions in human and mouse models. Human CD96 interacts with CD155 and ligation of this receptor activates NK cells, while in mice the presence of CD96 correlates with decreased NK cell activation. Mouse CD96 also binds nectin-1, but the effect of this interaction has not yet been determined. Here we show that human nectin-1 directly interacts with CD96 in vitro. The binding site for CD96 is located on the nectin-1 V-domain, which comprises a canonical interface that is shared by nectins to promote cell adhesion. The affinity of nectin-1 for CD96 is lower than for other nectins such as nectin-3 and nectin-1 itself. However, the affinity of nectin-1 for CD96 is similar to its affinity for herpes simplex virus glycoprotein D (HSV gD), which binds the nectin-1 V-domain during virus entry. The affinity of human CD96 for nectin-1 is lower than for its known activating ligand CD155. We also found that human erythroleukemia K562 cells, which are commonly used as susceptible targets to assess NK cell cytotoxicity did not express nectin-1 on their surface and were resistant to HSV infection. When expressed in K562 cells, nectin-1-GFP accumulated at cell contacts and allowed HSV entry. Furthermore, overexpression of nectin-1-GFP led to an increased susceptibility of K562 cells to NK-92 cell cytotoxicity.

Indexed as

AnimalsAntigens, CDBinding SitesCell LineCytotoxicity, ImmunologicHerpesvirus 1, HumanHumansK562 CellsKiller Cells, NaturalMiceNectinsProtein Interaction Domains and MotifsRecombinant Fusion ProteinsVirus InternalizationAntigens, CDCD96 antigenNECTIN1 protein, humanNECTIN3 protein, humanNectinsRecombinant Fusion Proteins

Identifiers

PMID30759143
PMCPMC6373967
OpenAlexW2911720976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.